Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015.

Matthew J Crowley Mugdha N GokhaleVirginia PateTil StürmerJohn B Buse

Published in: Diabetes, obesity & metabolism (2018)

Incidence rate differences in multiple CV outcomes appeared more favourable when DPP-4 inhibitor initiation occurred in the presence of metformin, suggesting a possible interaction between DPP-4 inhibitors and metformin.

Keyphrases

risk factors
health insurance
electronic health record
big data
type diabetes
metabolic syndrome
adipose tissue
affordable care act
deep learning
glycemic control